Nebulized Heparin in 2025: at the Interface between Promising Benefits and the Need
for Further Research
Authors
Giuseppe Lippi
1
Section of Clinical Biochemistry, University of Verona, Verona, Italy
Emmanuel J. Favaloro
2
Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR),
Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, Westmead, New South
Wales, Australia
3
Faculty of Science and Health, Charles Sturt University, Wagga Wagga, New South Wales,
Australia
4
School of Medical Sciences, Faculty of Medicine and Health, University of Sydney,
Westmead Hospital, Westmead, New South Wales, Australia
